Existing user? Sign in Start 7-day access →
Stocks · AUROPHARMA · F&O

Aurobindo Pharma share price & delivery.

Last close · 19 Oct 2026
₹1,621.40 -2.73%
Sector: Pharma & healthcare · RS rating 83
1W-5.0%1M-4.1%3M+4.0%6M+17.0%1Y+44.2%
52-week range
₹1,080.10-6.8% from the high₹1,740.00
Open in TradingView ↗

Price, volume and delivery

Candles adjusted for splits and bonuses. In the lower panel, the grey bar is the day’s volume and the coloured bar is the part that was delivered; bright green marks big-buyer days (delivered shares 3× the stock’s normal or more, with a normal-or-higher delivery %).

Aurobindo Pharma stock DNA

Where Aurobindo Pharma sits among the 1,422 most traded NSE stocks, on a 0–100 scale: 0 is the lowest of all of them, 100 the highest. From the last year of daily data. The first row is the RS rating used on our relative strength ranking.

Relative strength (RS rating)12-month return, latest quarter counted twice
Weak
Strong
83/100
Volatility26% a year
Calm
Wild
7/100
Daily range2.3% high to low
Tight
Wide
10/100
Opening gaps8% of days gap 1%+
Rare
Often
2/100
Delivery51% of volume delivered
Traders
Holders
60/100
Liquidity₹132 Cr a day
Thin
Deep
90/100
1-year return+44.2%
Laggard
Leader
85/100
Gap-ups of 1%+ (1 year)1457% filled the same day
Gap-downs of 1%+683% filled the same day
Up days50%of the last 250 sessions
Streak2 downsessions in a row

How Aurobindo Pharma usually moves

Every session of the last year by size of move. The white line is the last session.

-5.0% to -4.5%: 2 days-4.5% to -4.0%: 1 days-3.5% to -3.0%: 1 days-3.0% to -2.5%: 4 days-2.5% to -2.0%: 8 days-2.0% to -1.5%: 13 days-1.5% to -1.0%: 22 days-1.0% to -0.5%: 41 days-0.5% to +0.0%: 33 days+0.0% to +0.5%: 24 days+0.5% to +1.0%: 36 days+1.0% to +1.5%: 22 days+1.5% to +2.0%: 14 days+2.0% to +2.5%: 7 days+2.5% to +3.0%: 9 days+3.0% to +3.5%: 3 days+3.5% to +4.0%: 5 days+4.0% to +4.5%: 3 days+4.5% to +5.0%: 2 days-5%-4%-3%-2%-1%+0%+1%+2%+3%+4%+5%Dashed lines: a normal day, ±1.6%Last session -2.73%

Best day 30 Jan 2026 (+4.96%), worst 10 Feb 2026 (-6.61%).

Aurobindo Pharma vs NIFTY 50, one year

Both start at 100. The shaded gap is how far Aurobindo Pharma is ahead of or behind the market.

100Dec 25Mar 26Jun 26Sep 26Aurobindo Phar +50.3%NIFTY 50 -8.6%

Peers in Pharma & healthcare

The most traded stocks in the same sector. All Pharma & healthcare stocks and the sector’s trend →

Divi's Labs+38.50% 1YRS 88Apollo Hospitals-0.76% 1YRS 52Laurus Labs+135.66% 1YRS 97Sun Pharma+5.36% 1YRS 56Dr Reddy's+0.42% 1YRS 61Max Healthcare-28.54% 1YRS 14Torrent Pharma+29.43% 1YRS 72Lupin+0.10% 1YRS 42

Delivery and big-buyer days

Delivered shares change owners for real; intraday trades don’t. Days when delivery jumps far above normal often mean large investors were buying or selling.

Delivery, last session52%3.85 L shares
Average, 60 sessions51%1-year median 49%
Big-buyer days, 1 year13delivery 3× normal or more

Delivery calendar, last 12 months

Each square is a session. The brighter the green, the more shares were delivered compared with Aurobindo Pharma’s normal. Hover or tap a square for the day.

MWFNovDecJanFebMarAprMayJunJulAugSepOct
Hover a square
QuietBelow normalNormalHighBig-buyer day

Latest big-buyer days

What the price did on the day and five sessions later. Past moves only.

DateDeliveredvs normalDelivery %Day5 days later
4 Aug 202614.06 L3.2×63%+2.01%+4.55%
30 Jun 202619.64 L3.5×61%+2.02%+0.28%
29 Jun 202631.11 L5.6×67%-0.50%+3.04%
11 Mar 202612.63 L3.1×50%+1.47%-2.74%
9 Mar 202612.15 L3.0×56%+1.25%+2.59%
25 Feb 202619.46 L5.0×64%+4.05%+1.16%
19 Feb 202614.02 L3.9×40%+1.02%+4.21%
18 Feb 202611.43 L3.2×35%-2.28%+4.48%

Aurobindo Pharma timeline

Everything that happened to Aurobindo Pharma, newest first: deals, promoter filings, results, big-buyer days, new highs and big moves.

  • October 2026
  • 14 Oct
    Q2 FY27 results: -1.29% on the dayPublished 13 Oct, 16:00 (after the close); opening gap -0.04%.
  • August 2026
  • 7 Aug
    New 52-week high at ₹1,662.40First new high in 25 sessions.
  • 4 Aug
    Big-buyer day: 14.06 L shares delivered, 3.2× normal63% of the day’s volume was delivered; the price closed +2.01%.
  • July 2026
  • 21 Jul
    Q1 FY27 results: +1.29% on the dayPublished 20 Jul, 16:31 (after the close); opening gap +0.47%.
  • June 2026
  • 30 Jun
    Big-buyer day: 19.64 L shares delivered, 3.5× normal61% of the day’s volume was delivered; the price closed +2.02%.
  • 29 Jun
    Big-buyer day: 31.11 L shares delivered, 5.6× normal67% of the day’s volume was delivered; the price closed -0.50%.
  • 24 Jun
    New 52-week high at ₹1,550.90First new high in 23 sessions.
  • May 2026
  • 22 May
    Fell 5.4% in one sessionClosed at ₹1,463.50, about 3.3× a normal day’s move.
  • April 2026
  • 27 Apr
    Q4 FY26 results: +0.21% on the dayPublished 24 Apr, 15:31 (after the close); opening gap +0.08%.
  • 17 Apr
    Buy BackEx-date: buy before this day to be entitled. From NSE’s corporate actions.
  • March 2026
  • 11 Mar
    Big-buyer day: 12.63 L shares delivered, 3.1× normal50% of the day’s volume was delivered; the price closed +1.47%.
  • 10 Mar
    New 52-week high at ₹1,291.80First new high in over 20 sessions.
  • 9 Mar
    Big-buyer day: 12.15 L shares delivered, 3.0× normal56% of the day’s volume was delivered; the price closed +1.25%.
  • February 2026
  • 25 Feb
    Big-buyer day: 19.46 L shares delivered, 5.0× normal64% of the day’s volume was delivered; the price closed +4.05%.
  • 19 Feb
    Big-buyer day: 14.02 L shares delivered, 3.9× normal40% of the day’s volume was delivered; the price closed +1.02%.
  • 18 Feb
    Big-buyer day: 11.43 L shares delivered, 3.2× normal35% of the day’s volume was delivered; the price closed -2.28%.
  • 17 Feb
    Big-buyer day: 15.12 L shares delivered, 4.3× normal49% of the day’s volume was delivered; the price closed +0.18%.
  • 11 Feb
    Big-buyer day: 15.63 L shares delivered, 4.8× normal38% of the day’s volume was delivered; the price closed +2.00%.
  • 10 Feb
    Big-buyer day: 33.91 L shares delivered, 10.5× normal40% of the day’s volume was delivered; the price closed -6.61%.
  • 10 Feb
    Fell 6.6% in one sessionClosed at ₹1,124.10, about 4.1× a normal day’s move.
  • 3 Feb
    Big-buyer day: 14.02 L shares delivered, 4.4× normal50% of the day’s volume was delivered; the price closed +4.71%.
  • January 2026
  • 16 Jan
    Q3 FY26 results: -0.63% on the dayPublished 14 Jan, 16:09 (after the close); opening gap -0.50%.
  • October 2025
  • 17 Oct
    Q2 FY26 results: -0.48% on the dayPublished 17 Oct, 11:36 (during market hours); opening gap -0.03%.
  • August 2025
  • 8 Aug
    Interim Dividend - Rs 4 Per ShareEx-date: buy before this day to be entitled. From NSE’s corporate actions.
  • July 2025
  • 23 Jul
    Q1 FY26 results: +1.45% on the dayPublished 23 Jul, 14:58 (during market hours); opening gap +0.25%.
  • April 2025
  • 24 Apr
    Q4 FY25 results: +0.88% on the dayPublished 24 Apr, 14:34 (during market hours); opening gap +0.00%.
  • February 2025
  • 7 Feb
    Q3 FY25 results: -0.01% on the dayPublished 6 Feb, 22:04 (after the close); opening gap -0.57%.
  • November 2024
  • 11 Nov
    Q2 FY25 results: -2.90% on the dayPublished 9 Nov, 20:59 (on a non-trading day); opening gap +0.26%.

F&O snapshot

Near-month future and options for 19 Oct 2026. OI build-up for all stocks →

Futures₹1,623.80-2.52% on the day
Open interest1.38 Cr+3.90% on the day
Build-upShort Buildupprice and OI together
PCR0.55all expiries 0.58
Max pain₹1,6802026-10-27 expiry
Market-wide limit used38%ban at 95%

Futures price and open interest

Near-month futures and total futures open interest since Jul 2024. Rising OI with a rising price is fresh buying; with a falling price, fresh selling.

Last 20 sessions
Long build-up Short build-up Short covering Long unwinding

PCR and max pain history

Biggest open interest for the 27 Oct expiry: calls at 1,800 (often read as resistance), puts at 1,700 (often read as support).

PCR for all stocks → · Max pain record → · OI build-up & futures screener →

Results-day moves

How Aurobindo Pharma moved on each quarterly results day. Every result since 2007 →

Typical move±1.2%last 12 results
vs a normal day1.3×bigger than usual
Closed higher53%of 77 results
+3%-3%+7%-7%Q3 FY22: +4.32% on 10 Feb 2022+4.3Q3 FY22Q4 FY22: +1.87% on 1 Jun 2022+1.9Q1 FY23: +3.08% on 12 Aug 2022+3.1Q1 FY23Q2 FY23: -0.38% on 14 Nov 2022-0.4Q3 FY23: +6.33% on 10 Feb 2023+6.3Q3 FY23Q4 FY23: -0.58% on 29 May 2023-0.6Q1 FY24: +0.98% on 14 Aug 2023+1.0Q1 FY24Q2 FY24: +3.04% on 10 Nov 2023+3.0Q3 FY24: +1.55% on 12 Feb 2024+1.5Q3 FY24Q4 FY24: -3.13% on 27 May 2024-3.1Q1 FY25: +0.83% on 12 Aug 2024+0.8Q1 FY25Q2 FY25: -2.90% on 11 Nov 2024-2.9Q3 FY25: -0.01% on 7 Feb 2025-0.0Q3 FY25Q4 FY25: +0.88% on 24 Apr 2025+0.9Q1 FY26: +1.45% on 23 Jul 2025+1.5Q1 FY26Q2 FY26: -0.48% on 17 Oct 2025-0.5Q3 FY26: -0.63% on 16 Jan 2026-0.6Q3 FY26Q4 FY26: +0.21% on 27 Apr 2026+0.2Q1 FY27: +1.29% on 21 Jul 2026+1.3Q1 FY27Q2 FY27: -1.29% on 14 Oct 2026-1.3

Best and worst months

Average return in each calendar month since 2000. Full share price history →

Jan: average -0.26%, higher in 46% of years-0.3JanFeb: average -4.05%, higher in 30% of years-4.1FebMar: average +2.20%, higher in 59% of years+2.2MarApr: average +6.43%, higher in 74% of years+6.4AprMay: average +2.18%, higher in 48% of years+2.2MayJun: average +3.26%, higher in 67% of years+3.3JunJul: average +4.70%, higher in 63% of years+4.7JulAug: average +1.08%, higher in 59% of years+1.1AugSep: average +3.00%, higher in 44% of years+3.0SepOct: average -1.98%, higher in 50% of years-2.0OctNov: average +3.52%, higher in 54% of years+3.5NovDec: average +6.65%, higher in 65% of years+6.7Dec

My notes on Aurobindo Pharma

Private: saved only in this browser, never sent to us.

Questions

What is the 52-week high and low of Aurobindo Pharma?
Over the last 52 weeks, Aurobindo Pharma (AUROPHARMA) traded between ₹1,080.10 and ₹1,740.00 (adjusted for splits and bonuses). The last close of ₹1,621.40 on 19 Oct 2026 is 6.8% below the high.
What is the delivery percentage of Aurobindo Pharma?
On 19 Oct 2026, 52.3% of Aurobindo Pharma’s traded shares were delivered. The 60-session average is 50.7%, and its median over the last year is 48.5%.
How volatile is Aurobindo Pharma?
Aurobindo Pharma’s daily moves over the last year add up to 26% annual volatility, higher than 7% of the 1,422 most traded NSE stocks. Its average day spans 2.3% from high to low.
How much does Aurobindo Pharma move on results day?
Over its last 12 quarterly results, Aurobindo Pharma moved ±1.2% on average on the reaction day, about 1.3× a normal day, and closed higher 53% of the time.

Data from NSE’s daily files, adjusted for splits and bonuses. Past behaviour is not a forecast. This is information, not investment advice; ChartMine is not a SEBI-registered adviser.

See it live on your chart.ChartMine for TradingView.

Start 7-day access →How it works